These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 36395660)

  • 1. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
    Zhang Y; Li J; Pu K
    Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive prodrug-based cancer nanomedicine.
    Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
    EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.
    Zhou L; Wang H; Li Y
    Theranostics; 2018; 8(4):1059-1074. PubMed ID: 29463999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Abnormality-Oriented Nanomedicine Design.
    Zhou Q; Xiang J; Qiu N; Wang Y; Piao Y; Shao S; Tang J; Zhou Z; Shen Y
    Chem Rev; 2023 Sep; 123(18):10920-10989. PubMed ID: 37713432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
    Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy.
    Liao J; Jia Y; Wu Y; Shi K; Yang D; Li P; Qian Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1581. PubMed ID: 31429208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine.
    Song Y; Ding Y; Dong CM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1742. PubMed ID: 34310063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of smart nanomedicines for effective cancer treatment.
    Heshmati Aghda N; Dabbaghianamiri M; Tunnell JW; Betancourt T
    Int J Pharm; 2022 Jun; 621():121791. PubMed ID: 35525473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-Free Nanomedicine for Cancer Immunotherapy.
    Fu Y; Bian X; Li P; Huang Y; Li C
    J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
    Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
    Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
    van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
    Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
    Liu G; Lovell JF; Zhang L; Zhang Y
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antitumor therapy with targeted dual-nanomedicines.
    Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
    Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors.
    Han X; Xu Y; Geranpayehvaghei M; Anderson GJ; Li Y; Nie G
    Biomaterials; 2020 Feb; 232():119745. PubMed ID: 31918228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
    Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
    Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.